| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMAINTERNMED.2014.328 |
| P698 | PubMed publication ID | 24638908 |
| P50 | author | Emily Chew | Q24266614 |
| Charles B Eaton | Q40142297 | ||
| Alain G. Bertoni | Q42116477 | ||
| P2093 | author name string | Bradford B Worrall | |
| Denise E Bonds | |||
| Traci E Clemons | |||
| Jennifer Robinson | |||
| Judy Hsia | |||
| Lawrence J Fine | |||
| Molly Harrington | |||
| Writing Group for the AREDS2 Research Group | |||
| P433 | issue | 5 | |
| P921 | main subject | circulatory system | Q11068 |
| fatty acid | Q61476 | ||
| eye disease | Q3041498 | ||
| P304 | page(s) | 763-771 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial | |
| P478 | volume | 174 |
| Q52818918 | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. |
| Q50332949 | Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD. |
| Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
| Q90145015 | Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials |
| Q48517326 | Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. |
| Q38957329 | Carotenoids: biochemistry, pharmacology and treatment. |
| Q39255894 | Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease? |
| Q34490891 | Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial |
| Q47168426 | Effects of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation on Cardiovascular Mortality: The Importance of the Dose of DHA. |
| Q34518507 | Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration |
| Q30239897 | Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors |
| Q60950118 | Fish, Fish Oils and Cardioprotection: Promise or Fish Tale? |
| Q55176268 | Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care. |
| Q39039446 | Integrated Approaches to Drug Discovery for Oxidative Stress-Related Retinal Diseases. |
| Q41462386 | Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression |
| Q90367323 | Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants |
| Q92980824 | Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer |
| Q31015035 | Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration |
| Q38800270 | Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials? |
| Q41961558 | Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration. |
| Q35086434 | Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction |
| Q30235305 | Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. |
| Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q26747026 | Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease |
| Q92755400 | Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials |
| Q40405513 | Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists |
| Q57689012 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q93360900 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q47633216 | Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids |
| Q47140914 | The CAPN2/CAPN8 Locus on Chromosome 1q Is Associated with Variation in Serum Alpha-Carotene Concentrations |
| Q35716443 | The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study |
| Q58722677 | The Effect of Lutein on Eye and Extra-Eye Health |
| Q92255416 | The Mediterranean Diet Slows Down the Progression of Aging and Helps to Prevent the Onset of Frailty: A Narrative Review |
| Q61806326 | The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging |
| Q90054212 | Triglycerides and Cardiovascular Outcomes-Can We REDUCE-IT ? |
| Q64951164 | Zeaxanthin Isolated from Dunaliella salina Microalgae Ameliorates Age Associated Cardiac Dysfunction in Rats through Stimulation of Retinoid Receptors. |
| Q47396742 | n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises; A Contemporary Review. |
Search more.